Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
P
Pharmala Biotech Holdings Inc
OTC:MDXXF
Pharmala Biotech Holdings Inc
OTC:MDXXF
Price:
0.1285
USD
6.46%
Market Closed
Market Cap:
$11.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pharmala Biotech Holdings Inc
OTC:MDXXF
|
CA |
|
BioNxt Solutions Inc
XETRA:BXT
|
CA |
|
Kimball Electronics Inc
NASDAQ:KE
|
US |
|
MetExtra Group SpA
MIL:MET
|
IT |
|
D
|
DHSteel
KOSDAQ:021045
|
KR |
|
H
|
Huazhu Group Ltd
NASDAQ:HTHT
|
CN |
|
SPC Global Holdings Ltd
ASX:SPG
|
AU |
|
Kingfisher PLC
F:KFI2
|
UK |
|
S
|
Synopsys Inc
XMUN:SYP
|
US |
|
Beijing Tong Ren Tang Co Ltd
SSE:600085
|
CN |
|
Big Medya Teknoloji AS
IST:BIGTK.E
|
TR |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
D
|
Duke Energy Corp
DUS:D2MN
|
US |
|
R
|
Rovsing A/S
CSE:ROV
|
DK |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDXXF's stock price target?
Not Available
MDXXF does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Pharmala Biotech Holdings Inc?
Projected CAGR
47%
47%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 94%. The projected CAGR for the next 3 years is 47%.